Results 251 to 260 of about 204,314 (304)

Primary health care nursing integration: Bridging the gap with co-designed shared care [PDF]

, 2018
Batten, L, Bevan, M, Cooper, P, Davies, D   +3 more
core  

Mapping the Burden and Risk Factors of Allergic Diseases and Asthma Among Aboriginal and Torres Strait Islander People: A Scoping Review

Clinical &Experimental Allergy, EarlyView.
Our study reveals Aboriginal and Torres Strait Islander people have a high allergy burden, with asthma the most prevalent; yet they remain under‐represented in research. ABSTRACT Allergic diseases and asthma are significant public health concerns in Australia and globally.
Desalegn Markos Shifti, Erin Pitt, Lesley Versteegh, Rani Scott Farmer, Catherine J. Hornung, Victoria Gibson, Diane Maresco‐Pennisi, Shyamali C. Dharmage, Anne B. Chang, Jennifer J. Koplin   +9 more
wiley   +1 more source

Prenatal exposure to a mixture of per- and polyfluoroalkyl substances (PFAS) and lung function and immune-related outcomes among males in childhood and young adulthood. [PDF]

Environ Res
Hull SD, Ferguson KK, London SJ, Hougaard KS, Lindh C, Petersen KU, Flachs EM, Wise LA, Wilcox AJ, Liew Z, Ramlau-Hansen CH, Toft G, Bonde JP, Tøttenborg SS.   +13 more
europepmc   +1 more source

A pilot study on the cutaneous effects of ethanol in a moisturizing cream on non-lesional skin of patients with atopic dermatitis. [PDF]

Sci Rep
Celikoglu M, Raab C, Vollert H, Harder J, Liu X, Baines JF, Fluhr JW, Keck CM, Infante VHP, Meinke MC.   +9 more
europepmc   +1 more source

Early and Sustained Asthma Control and Remission in Real‐World Patients With Severe Eosinophilic Asthma Treated With Benralizumab: XALOC‐2

Clinical &Experimental Allergy, EarlyView.
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz, Thomas Rothe, Lieven Dupont, Trung N. Tran, Andrew Menzies‐Gow, Anat Shavit, David Cohen, Tanja Plate, Sheena Kayaniyil, An Herreman, Claudio Schuoler, Benjamin Emmanuel, Marek Lommatzsch   +12 more
wiley   +1 more source

Atopic dermatitis associated with systemic tacrolimus: Case report and review. [PDF]

SAGE Open Med Case Rep
Luijk SJK, Sibbald CJ.
europepmc   +1 more source

Increased Levels of Inflammatory Proteins, Including TARC/CCL17, in Skin of AD Patients During JAK Inhibitor Treatment

Clinical &Experimental Allergy, Volume 55, Issue 3, Page 260-263, March 2025.
Celeste M. Boesjes, Lian F. van der Gang, Daphne S. Bakker, C. F. den Hartog Jager, Marlies de Graaf, Marjolein S. de Bruin‐Weller, Femke van Wijk, Edward F. Knol   +7 more
wiley   +1 more source

Classification of skin diseases with deep learning based approaches. [PDF]

Sci Rep
Sarı MO, Keser K.
europepmc   +1 more source

Characteristics and Clinical Management of Eosinophilic Esophagitis in Australia: A National Survey

Clinical &Experimental Allergy, EarlyView.
A. Clancy, A. Swain, E. Beck, V. Soutter, R. Loblay   +4 more
wiley   +1 more source

Assessing Atopic Dermatitis Control in Chinese Patients: Validation of the Chinese Version of Recap of Atopic Eczema Questionnaire (RECAP) and an Investigation into Its Interpretability. [PDF]

Acta Derm Venereol
Zhang J, Zhu S, Yuan L, Yu X, Ling S, Zhang J, Yang B.   +6 more
europepmc   +1 more source